Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/16/1999US5883228 Functionally active regions of signal transducer and activator of transcription
03/16/1999US5883227 Multiple sclerosis associated polypeptide
03/16/1999US5883226 Nucleotide sequences of genes
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5883224 Characterization of transfer factors and methods of use
03/16/1999US5883223 CD9 antigen peptides and antibodies thereto
03/16/1999US5883082 Compositions and methods for preventing and treating allograft rejection
03/16/1999US5883081 Isolation of novel HIV-2 proviruses
03/16/1999US5883076 Inducing plant defense mechanisms; wound healing agents; genetic engineering; gene expression
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5883073 Single-chain double-alpha peptide
03/16/1999US5883071 Mammalian growth factor
03/16/1999US5882945 Isolation, expression, immunizing and antibodies
03/16/1999US5882944 Methods for G protein coupled receptor activity screening
03/16/1999US5882927 Oligonucleotide inhibition of protein kinase C
03/16/1999US5882926 Nucleic acid hybridization probes; genetic engineering; gene expression; diagnosing genetic disorders
03/16/1999US5882925 Cdna contained in plasmids, amino acid sequences and cultures
03/16/1999US5882924 Dna encodes fusion proteins
03/16/1999US5882914 Nucleic acids encoding the hypoxia inducible factor-1
03/16/1999US5882899 Binds to pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide; gene expression
03/16/1999US5882898 Cells and vectors with polynucleotides
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof
03/16/1999US5882893 Modulation of acetylcholine responses in cells; antisense molecules; expression vectors; genetic engineering; nervous system, cardiovascular, glandular, eating, psychological, and smooth muscle disorders
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882890 Nucleic acid and amino acid sequences of novel regulators of g-protein signaling and to the use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation and inflammation
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882887 Proteins for genetic engineering
03/16/1999US5882884 Expression of proteinaceous sweeteners in yeast
03/16/1999US5882880 Dna sequences and cell progression for cancer treatment
03/16/1999US5882877 Cystic fibrosis treatment; genetic engineering
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882875 Methods for identifying multidrug resistant tumor cells
03/16/1999US5882873 Human DNA sequence encoding a kidney ATP-dependent potassium channel
03/16/1999US5882871 Saliva binding protein
03/16/1999US5882868 Method of diagnosing spinal muscular atrophy
03/16/1999US5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
03/16/1999US5882862 Human radioresistance/cell cycle progression gene
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882858 Cloning and uses of the genetic locus BCL-6
03/16/1999US5882855 DNA encoding a human dopamine D1 receptor and uses thereof
03/16/1999US5882853 Culture of t-cells for patients to form polypeptides
03/16/1999US5882852 Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
03/16/1999US5882668 Maize protein for insect control
03/16/1999US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant
03/16/1999US5882654 Polyvalent melanoma vaccine
03/16/1999US5882653 Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
03/16/1999US5882652 Empty canine parvovirus capsids having CPV recombinant VP2 and vaccines having such capsids
03/16/1999US5882650 Influenza a virus ns1 protein, or a t cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response
03/16/1999US5882645 Peptide compounds
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5882642 Genetically engineered transmissible hypovirulence
03/16/1999CA2236363A1 Novel compound
03/16/1999CA2019463C Antibiotics plusbacin
03/16/1999CA2008825C Reg protein
03/16/1999CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
03/16/1999CA1340446C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
03/16/1999CA1340437C Interleukin 2 receptor and applications thereof
03/16/1999CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
03/11/1999WO1999012038A1 Detection of measles virus-specific antibodies
03/11/1999WO1999012037A1 Compositions and methods for the treatment of inflammatory bowel disease
03/11/1999WO1999011824A1 An alpha-2 macroglobulin diagnostic test
03/11/1999WO1999011812A1 TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 6q27 AND USES THEREOF
03/11/1999WO1999011809A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999WO1999011808A1 Rna respiratory syncytial virus vaccines
03/11/1999WO1999011803A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria
03/11/1999WO1999011791A2 Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
03/11/1999WO1999011790A1 Tumor necrosis factor receptor ztnfr-6
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011787A1 DNA PARTICIPATING IN REGULATION OF EXPRESSION O PEBP2 αA GENE, AND USE THEREOF
03/11/1999WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY
03/11/1999WO1999011785A1 Chimeric binding peptide library screening method
03/11/1999WO1999011784A1 Proton gated ion channel proteins
03/11/1999WO1999011783A2 T-box polypeptides
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses
03/11/1999WO1999011777A1 Methods for protein screening
03/11/1999WO1999011776A1 A cell-free replication system and uses thereof
03/11/1999WO1999011775A1 Mutant mhc class i molecules
03/11/1999WO1999011774A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011669A1 Diagnosis, prevention and treatment of diabetes
03/11/1999WO1999011668A1 Dna molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby
03/11/1999WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011665A1 Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same
03/11/1999WO1999011664A1 Genetically engineered cells which express bone morphogenetic proteins
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011662A1 Novel molecules of the tnfr-ligand-related protein family and uses thereof
03/11/1999WO1999011661A1 Biomolecules comprising an elastomeric peptide
03/11/1999WO1999011660A2 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
03/11/1999WO1999011656A1 Protein composition and process for isolating a protein composition from a muscle source
03/11/1999WO1999011655A1 Modular protein libraries and methods of preparation
03/11/1999WO1999011654A1 Randomly generated glycopeptide combinatorial libraries
03/11/1999WO1999011652A1 Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
03/11/1999WO1999011589A1 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation
03/11/1999WO1999011293A1 50 human secreted proteins